RespireRx
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia Opiate Induced Respiratory Depression | Phase 2 | 2016-03-01 |
| Completed | CX717 in the Treatment of Adult ADHD Attention Deficit Hyperactivity Disorder | Phase 2 | 2005-07-19 |
| Completed | Effects of CX516 on Functioning in Fragile X Syndrome and Autism Fragile X Syndrome, Autism | Phase 2 | 2002-06-01 |
| Completed | Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment. Mild Cognitive Impairment | Phase 2 | 2002-04-01 |